The Life Science business of Merck KGaA, Darmstadt, Germany Becomes a Trusted Partner of the Flemingsberg Science Foundation

Flemingsberg, 2025-06-23

The Life Science business of Merck KGaA, Darmstadt, Germany, and Flemingsberg Science Foundation collaborate to promote Life Science sector in Flemingsberg. This strategic partnership aims to strengthen development of ATMP (Advanced Therapy Medicinal Products).

Given the rapid development of ATMP (Advanced Therapy Medicinal Products) in Flemingsberg, the foundation seeks to create a strong support network for individuals and companies within the Life Science sector. Through this partnership with the Life Science business of Merck KGaA, Darmstadt, Germany, Flemingsberg Science Foundation is taking another significant step towards building a robust infrastructure for innovation and growth in the region.

“Together with the foundation and other partners, we will contribute by identifying growth opportunities, infrastructure needs, and investment areas that can further develop the ATMP environment in Flemingsberg. Through our presence in Flemingsberg, we can efficiently and effectively meet the specific needs of companies and organizations within the ATMP sector.” – Gianluca Tagliapietra, Senior VP Commercial SLS EMEA, the Life Science business of Merck KGaA, Darmstadt, Germany.

“The Life Science business of Merck KGaA, Darmstadt, Germany provides cutting-edge technology, expertise, and strategic partnerships that strengthen the life science cluster in Flemingsberg in multiple ways, both directly and in the long term. Their presence creates opportunities for our companies and organizations to benefit from their expertise and enables collaborations through meetings and events. Together with our other trusted partners, they also contribute the knowledge and network we need to continue developing Flemingsberg, as well as the platform ATMP Flemingsberg”. – Johnny Högberg, CEO of the Flemingsberg Science Foundation.

As a trusted partner, the Life Science business of Merck KGaA, Darmstadt, Germany, will, among other things, organize at least three events per year, become a member of Novum Labs – an innovative environment with state-of-the-art laboratory facilities and room for growth – and host workshops, seminars, and panel discussions on regulatory challenges, commercialization, and scientific advancements.

This partnership is part of the initiative to strengthen the growth and establishment of small and medium-sized enterprises (SMEs) in the life science sector in the Stockholm region.

Johnny Högberg
CEO, stiftelsen Flemingsberg Science
johnny.hogberg@flemingsbergscience.se
070 550 12 73

Merck, a leading science and technology company, operates across life science, healthcare and electronics. More than 62,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From providing products and services that accelerate drug development and manufacturing as well as discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2024, Merck generated sales of € 21.2 billion in 65 countries.

 Scientific exploration and responsible entrepreneurship have been key to Merck’s technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as MilliporeSigma in life science, EMD Serono in healthcare, and EMD Electronics in electronics.

A national resource for tomorrow’s treatments – Karolinska ATMP Center is now inaugurated

With a clear message of hope for the future and a powerful spirit of collaboration, the Karolinska ATMP Center in Flemingsberg was inaugurated at the end of August. The center is a collaboration between Karolinska Institutet and Karolinska University Hospital and will serve as a national resource for the production of advanced therapies (ATMPs), where research, clinical trials, and treatments work seamlessly together to deliver groundbreaking therapies to patients.

Meetings That Shape the Future: Flemingsberg Science at Almedalen

In June this year, the foundation took part in the annual Almedalen Week, the world’s largest democratic meeting place for everyone who wants to join the discussions on current societal issues. This year, we had a special focus on Life Science, an area and cluster that has long been a natural part of Flemingsberg, and which is now growing stronger than ever.

Meet us at NLSDays

In the south of Stockholm you’ll find Flemingsberg, home to a vibrant life science cluster that’s rapidly emerging as an attractive location for life science companies. Here, academia, business and society form a dynamic ecosystem, fueling innovation and growth. And with more companies establishing and collaborations further deepening, the opportunity to expand and invest have never been greater. This year, we are therefore participating in NLSDays in Gothenburg, where we will showcase Flemingsberg's unique strengths and invite more stakeholders to become part of our thriving life science environment. 

Want to know more? Subscribe to our newsletter.

SUBSCRIBE
CF_logo_neg

Want to know more? Subscribe to our newsletter.

CF_logo_neg
fb yt insta
fb yt insta
Go to Top